Noah Helman is an accomplished inventor based in South San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in enzyme engineering and microbial production processes. With a total of six patents to his name, Helman's work has the potential to impact various industries, including biofuels and bioproducts.

Latest Patents

One of Helman's latest patents is focused on enzyme variants with improved ester synthase properties. This patent discloses enzyme variants that enhance the production of fatty acid esters. It also includes recombinant host cells that express these variants, along with cell cultures and fatty acid ester compositions produced by such recombinant host cells. Another notable patent involves the microbial production of fatty diols. This patent details recombinant microorganisms engineered to produce fatty diols through fermentation, utilizing a simple carbon source in the process.

Career Highlights

Throughout his career, Noah Helman has worked with prominent companies in the biotechnology sector. He has been associated with Genomatica, Inc. and Reg Life Sciences, LLC, where he has contributed to innovative projects and research initiatives. His expertise in enzyme engineering and microbial processes has positioned him as a valuable asset in these organizations.

Collaborations

Helman has collaborated with several professionals in his field, including Kevin Holden and Andrew M. Shumaker. These collaborations have fostered a productive environment for innovation and research, leading to advancements in biotechnology.

Conclusion

Noah Helman's contributions to the field of biotechnology through his patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in enzyme engineering and microbial production processes.

This text is generated by artificial intelligence and may not be accurate.